Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25

The bill was amended to clarify reporting requirements for 340B drug programs and to condition the bill's effectiveness on the passage of companion legislation. The most significant substantive change is the modification of the reporting deadline, shifting the annual submission date from July 1, 2026, to an unspecified future date pending the enactment of related bills. Additionally, the required content of the 340B entity reports was slightly altered to include the impact on patients and the community, while the specific list of required documents was streamlined. The bill also updated the mechanism for determining when the law takes effect, requiring the passage of specific companion bills instead of a single referenced bill.